IP & Drug Development

Our Approach to Drug Discovery

The invention and development of novel psychedelic and non-psychedelic molecules for medical use is an important part of our research strategy. We use molecules found in nature as building blocks to make improved second-generation drugs. This portfolio of new drugs represents major improvements to existing natural products, as well as the synthetics, that include enhanced safety, efficacy, stability, dosing, and reduced side effects.

Using Research to Understand the Power of Psychedelics

Using Research to Understand the Power of Psychedelics

The goal of creating these improved second-generation compounds is to enable safer, more effective treatments for patients along with improved management of dosage and drug behavior for clinicians. In order to create these enhanced molecules, we study the large number of psychedelics reported in the literature as well as anecdotal reports, to gain an understanding of how these drugs have been used therapeutically, and more importantly, what their shortcomings are.

Breaking Down Psychedelics for Their Best Use

Breaking Down Psychedelics for Their Best Use

A thorough analysis of each drug on a molecular level, allows us to determine which features are responsible for undesirable effects and shortcomings. This information is then used to design new second generation molecules with the desired improved performance which allows better management in the clinicians’ hands.

Evolving Nature to Its Most Powerful Being

Evolving Nature to Its Most Powerful Being

The current generation of psychedelic natural products evolved in nature making them most equipped to deal with the organism’s natural environment. Although these molecules have been found remarkably useful for therapeutic use, they are not naturally made for a clinical setting, therefore, there is an immense demand for these next generation drugs that will be responsive to the needs of the patients and physicians.